大洋洲 · 区域市场 · Stockhead

TrivarX takes key step towards trial of next-gen cancer imaging technology

来源：Stockhead · 澳大利亚 1 小时前

Syntro Health will undertake laboratory formulation activities for the Stabl-Im investigational product, with TrivarX (ASX:TRI) targeting first patient enrolment in ... Read More…

在 Stockhead 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stockhead.com.au)

TrivarX takes key step towards trial of next-gen cancer imaging technology

推荐阅读

3 buy-rated ASX growth shares with big international ambitions

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Australian businesses pull websites offline over PHP threat

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

TrivarX takes key step towards trial of next-gen cancer imaging technology

分享

推荐阅读

3 buy-rated ASX growth shares with big international ambitions

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Australian businesses pull websites offline over PHP threat

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million